Details

Autor(en) / Beteiligte

• Wesselhoeft, R.
• Jensen, P. B.
• Talati, A.
• Reutfors, J.
• Furu, K.
• Strandberg‐Larsen, K.
• Damkier, P.
• Pottegård, A.
• Bliddal, M.

Titel

Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study

Ist Teil von

• Acta psychiatrica Scandinavica, 2020-01, Vol.141 (1), p.34-42

Ort / Verlag

United States: Blackwell Publishing Ltd

Erscheinungsjahr

2020

Link zum Volltext

Quelle

Wiley Online Library - AutoHoldings Journals

Beschreibungen/Notizen

• Objective To compare antidepressant utilization in individuals aged 5–19 years from the Scandinavian countries. Methods A population‐based drug utilization study using publicly available data of antidepressant use from Denmark, Norway, and Sweden. Results In the study period from 2007 to 2017, the proportion of antidepressant users increased markedly in Sweden (9.3–18.0/1000) compared to Norway (5.1–7.6/1000) and Denmark (9.3–7.5/1000). In 2017, the cumulated defined daily doses (DDD) of selective serotonin reuptake inhibitors were 5611/1000 inhabitants in Sweden, 2709/1000 in Denmark, and 1848/1000 in Norway. The use of ‘other antidepressants' (ATC code N06AX) also increased in Sweden with a higher DDD in 2017 (497/1000) compared to Denmark (225/1000) and Norway (170/1000). The use of tricyclic antidepressants was generally low in 2017 with DDDs ranging between 30–42 per 1000. The proportion of antidepressant users was highest among 15‐ to 19‐year‐old individuals. Girls were more likely to receive treatment than boys, and the treated female/male ratios per 1000 were similar in Sweden (2.39), Denmark (2.44), and Norway (2.63). Conclusion Even in highly comparable healthcare systems like the Scandinavian countries', variation in antidepressant use is considerable. Swedish children and adolescents have a markedly higher and still increasing use of antidepressants compared to Danish and Norwegian peers.